ThermaGenix, founded in 2016 by Professor Lawrence Wangh of Brandeis University, is a leading provider of high-performance PCR additives for scientists worldwide. With exclusive licenses to the ThermaStop, ThermaGo, and ThermaStopRT patents, ThermaGenix is dedicated to enhancing polymerase specificity and fidelity, resulting in superior amplicons for a wide range of applications, from genotyping to diagnostics and next-generation sequencing sample preparation.
Driven by a team of passionate individuals with a proven track record in inventing and commercializing innovative life science products, ThermaGenix is committed to empowering scientists with cutting-edge PCR technology. With expertise in advanced PCR techniques and over 29 patents, including the invention of LATE-PCR, founder Lawrence Wangh and President Peter Coassin bring decades of experience in life science product invention and innovation to the company's mission of maximizing PCR performance.
Generated from the website